Arrowhead Pharmaceuticals
ARWR
#1802
Rank
NZ$20.49 B
Marketcap
NZ$145.50
Share price
-0.44%
Change (1 day)
312.07%
Change (1 year)

Earnings for Arrowhead Pharmaceuticals (ARWR)

Earnings in 2026 (TTM): -NZ$0.27 Billion

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current earnings are NZ$0.62 Billion. In 2025 the company made an earning of NZ$0.57 Billion, an increase over its 2024 earnings that were of -NZ$1.01 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arrowhead Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.27 Billion-145.61%
2025 NZ$0.57 B-157.5%
2024 -NZ$1.01 Billion112.45%
2023 -NZ$0.48 Billion87.79%
2022 -NZ$0.26 Billion-20.1%
2021 -NZ$0.32 Billion67.59%
2020 -NZ$0.19 Billion-347.53%
2019 NZ$76.14 M-245.59%
2018 -NZ$52.31 Million-13.17%
2017 -NZ$60.24 Million-52.28%
2016 -NZ$0.13 Billion-16.57%
2015 -NZ$0.16 Billion30.32%
2014 -NZ$0.12 Billion171.62%
2013 -NZ$42.75 Million16.56%
2012 -NZ$36.68 Million107.53%
2011 -NZ$17.68 Million
2008 -NZ$62.25 Million-8.07%
2007 -NZ$67.71 Million70.37%
2006 -NZ$39.75 Million122.51%
2005 -NZ$17.87 Million147.41%
2004 -NZ$7.22 Million2002.28%
2003 -NZ$0.35 Million-85.61%
2002 -NZ$2.39 Million1371.97%
2001 -NZ$0.17 Million-13.45%
2000 -NZ$0.19 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$43.58 B-16,353.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-NZ$5.23 Billion 1,847.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$0.31 B-219.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-NZ$0.2 Billion-26.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$1.45 B-644.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-NZ$0.15 Billion-45.44%๐Ÿ‡บ๐Ÿ‡ธ USA